Venrock Adviser, LLC Diversified Active

Location: New York, NY

CIK: 0001615982 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $1.777B (100.0% shares, 0.0% debt)

Holdings (33)

APGE APOGEE THERAPEUTICS INC 19.0%

Value $337M Shares 8,493,321 Est. Cost $22.03 Unrealized +73.3%

— METSERA INC 11.0%

Value $196M Shares 3,750,662 Est. Cost $27.22 Unrealized —

OCUL OCULAR THERAPEUTIX INC 8.7%

Value $154M Shares 13,161,462 Est. Cost $4.80 Unrealized +149.2%

— CIDARA THERAPEUTICS INC 5.1%

Value $90.66M Shares 946,788 Est. Cost $48.29 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 4.7%

Value $83.79M Shares 3,882,709 Est. Cost $19.32 Unrealized -6.6%

KALV KALVISTA PHARMACEUTICALS INC 4.6%

Value $81.96M Shares 6,728,985 Est. Cost $8.91 Unrealized +55.1%

ORKA ORUKA THERAPEUTICS INC 4.5%

Value $79.77M Shares 4,148,428 Est. Cost $29.65 Unrealized -50.0%

ORIC ORIC PHARMACEUTICALS INC 4.5%

Value $79.16M Shares 6,596,885 Est. Cost $7.60 Unrealized +38.4%

ELVN ENLIVEN THERAPEUTICS INC 3.7%

Value $66.04M Shares 3,226,331 Est. Cost $18.38 Unrealized +9.7%

COGT COGENT BIOSCIENCES INC 3.2%

Value $57.44M Shares 4,000,000 Est. Cost $8.47 Unrealized +39.9%

CTMX CYTOMX THERAPEUTICS INC 2.8%

Value $49.64M Shares 15,561,500 Est. Cost $1.68 Unrealized +34.3%

ABVX ABIVAX SA 2.8%

Value $48.96M Shares 576,729 Est. Cost $11.63 Unrealized —

SVRA SAVARA INC 2.5%

Value $45.27M Shares 12,681,043 Est. Cost $2.80 Unrealized +5.6%

SYRE SPYRE THERAPEUTICS INC 2.5%

Value $45.01M Shares 2,685,448 Est. Cost $17.59 Unrealized -7.3%

ERAS ERASCA INC 2.2%

Value $38.93M Shares 17,857,083 Est. Cost $2.08 Unrealized -23.6%

DNTH DIANTHUS THERAPEUTICS INC 2.1%

Value $37.81M Shares 960,803 Est. Cost $17.70 Unrealized +44.4%

ENGN ENGENE HOLDINGS INC 1.9%

Value $34.47M Shares 5,046,414 Est. Cost $10.25 Unrealized -55.5%

MAZE MAZE THERAPEUTICS INC 1.8%

Value $31.91M Shares 1,230,769 Est. Cost $16.88 Unrealized 0.0%

JBIO JADE BIOSCIENCES INC 1.6%

Value $27.79M Shares 3,220,364 Est. Cost $33.31 Unrealized -75.5%

DYN DYNE THERAPEUTICS INC 1.5%

Value $27.5M Shares 2,173,913 Est. Cost $11.80 Unrealized -3.3%

VOR VOR BIOPHARMA INC 1.4%

Value $24.36M Shares 499,966 Est. Cost $40.21 Unrealized 0.0%

UPB UPSTREAM BIO INC 1.2%

Value $21.99M Shares 1,169,298 Est. Cost $22.33 Unrealized -30.4%

ZURA ZURA BIO LTD 1.1%

Value $20.05M Shares 4,631,216 Est. Cost $2.58 Unrealized -30.4%

— ASTRIA THERAPEUTICS INC 1.0%

Value $17.89M Shares 2,457,348 Est. Cost $8.36 Unrealized —

PHVS PHARVARIS N V 0.9%

Value $16.83M Shares 674,599 Est. Cost $15.96 Unrealized +38.9%

CBIO CRESCENT BIOPHARMA INC. 0.9%

Value $16.5M Shares 1,387,864 Est. Cost $21.15 Unrealized -37.3%

SEPN SEPTERNA INC 0.6%

Value $11.49M Shares 610,808 Est. Cost $8.80 Unrealized +49.2%

CGEM CULLINAN THERAPEUTICS INC 0.5%

Value $8.183M Shares 1,379,965 Est. Cost $21.29 Unrealized -65.6%

SRZN SURROZEN INC 0.5%

Value $8.155M Shares 632,931 Est. Cost $11.62 Unrealized -9.8%

PCSC PERCEPTIVE CAP SOLUTIONS COR 0.4%

Value $7.95M Shares 750,000 Est. Cost $10.07 Unrealized +5.1%

ARTV ARTIVA BIOTHERAPEUTICS INC 0.3%

Value $4.619M Shares 1,609,569 Est. Cost $11.59 Unrealized -76.9%

TENX TENAX THERAPEUTICS INC 0.2%

Value $3.331M Shares 437,708 Est. Cost $5.55 Unrealized +10.1%

CASIF CASI PHARMACEUTICALS INC 0.1%

Value $1.639M Shares 987,259 Est. Cost $6.09 Unrealized -70.7%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
APGE	APOGEE THERAPEUTICS INC	8,493,321	$337M	19.0%	$22.03	+73.3%	COM	03770N101
—	METSERA INC	3,750,662	$196M	11.0%	$27.22	—	COM	59267L107
OCUL	OCULAR THERAPEUTIX INC	13,161,462	$154M	8.7%	$4.80	+149.2%	COM	67576A100
—	CIDARA THERAPEUTICS INC	946,788	$90.66M	5.1%	$48.29	—	COM NEW	171757206
VRDN	VIRIDIAN THERAPEUTICS INC	3,882,709	$83.79M	4.7%	$19.32	-6.6%	COM	92790C104
KALV	KALVISTA PHARMACEUTICALS INC	6,728,985	$81.96M	4.6%	$8.91	+55.1%	COM	483497103
ORKA	ORUKA THERAPEUTICS INC	4,148,428	$79.77M	4.5%	$29.65	-50.0%	COM	687604108
ORIC	ORIC PHARMACEUTICALS INC	6,596,885	$79.16M	4.5%	$7.60	+38.4%	COM	68622P109
ELVN	ENLIVEN THERAPEUTICS INC	3,226,331	$66.04M	3.7%	$18.38	+9.7%	COM	29337E102
COGT	COGENT BIOSCIENCES INC	4,000,000	$57.44M	3.2%	$8.47	+39.9%	COM	19240Q201
CTMX	CYTOMX THERAPEUTICS INC	15,561,500	$49.64M	2.8%	$1.68	+34.3%	COM	23284F105
ABVX	ABIVAX SA	576,729	$48.96M	2.8%	$11.63	—	SPONSORED ADS	00370M103
SVRA	SAVARA INC	12,681,043	$45.27M	2.5%	$2.80	+5.6%	COM	805111101
SYRE	SPYRE THERAPEUTICS INC	2,685,448	$45.01M	2.5%	$17.59	-7.3%	COM NEW	00773J202
ERAS	ERASCA INC	17,857,083	$38.93M	2.2%	$2.08	-23.6%	COM	29479A108
DNTH	DIANTHUS THERAPEUTICS INC	960,803	$37.81M	2.1%	$17.70	+44.4%	COM	252828108
ENGN	ENGENE HOLDINGS INC	5,046,414	$34.47M	1.9%	$10.25	-55.5%	COM	29286M105
MAZE	MAZE THERAPEUTICS INC	1,230,769	$31.91M	1.8%	$16.88	0.0%	COM	578784100
JBIO	JADE BIOSCIENCES INC	3,220,364	$27.79M	1.6%	$33.31	-75.5%	COM NEW	008064206
DYN	DYNE THERAPEUTICS INC	2,173,913	$27.5M	1.5%	$11.80	-3.3%	COM	26818M108
VOR	VOR BIOPHARMA INC	499,966	$24.36M	1.4%	$40.21	0.0%	COM NEW	929033207
UPB	UPSTREAM BIO INC	1,169,298	$21.99M	1.2%	$22.33	-30.4%	COM	91678A107
ZURA	ZURA BIO LTD	4,631,216	$20.05M	1.1%	$2.58	-30.4%	CLASS A ORD SHS	G9TY5A101
—	ASTRIA THERAPEUTICS INC	2,457,348	$17.89M	1.0%	$8.36	—	COM	04635X102
PHVS	PHARVARIS N V	674,599	$16.83M	0.9%	$15.96	+38.9%	COM	N69605108
CBIO	CRESCENT BIOPHARMA INC.	1,387,864	$16.5M	0.9%	$21.15	-37.3%	COM	G2545C104
SEPN	SEPTERNA INC	610,808	$11.49M	0.6%	$8.80	+49.2%	COM	81734D104
CGEM	CULLINAN THERAPEUTICS INC	1,379,965	$8.183M	0.5%	$21.29	-65.6%	COM	230031106
SRZN	SURROZEN INC	632,931	$8.155M	0.5%	$11.62	-9.8%	COM NEW	86889P208
PCSC	PERCEPTIVE CAP SOLUTIONS COR	750,000	$7.95M	0.4%	$10.07	+5.1%	CL A ORD SHS	G70077105
ARTV	ARTIVA BIOTHERAPEUTICS INC	1,609,569	$4.619M	0.3%	$11.59	-76.9%	COM	04317A107
TENX	TENAX THERAPEUTICS INC	437,708	$3.331M	0.2%	$5.55	+10.1%	COM NEW	88032L605
CASIF	CASI PHARMACEUTICALS INC	987,259	$1.639M	0.1%	$6.09	-70.7%	ORD SHS	G1933S101